Stonegate Investment Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$421K Sell
2,680
-1,315
-33% -$203K 0.01% 270
2025
Q2
$671K Buy
3,995
+112
+3% +$16.6K 0.02% 208
2025
Q1
$535K Sell
3,883
-54
-1% -$6.88K 0.01% 208
2024
Q4
$466K Buy
3,937
+54
+1% +$6.3K 0.01% 223
2024
Q3
$429K Buy
3,883
+1,718
+79% +$180K 0.01% 248
2024
Q2
$213K Buy
+2,165
New +$221K 0.01% 330

Other funds holding CAH

Stonegate Investment Group's CAH Position: Q3 2025 in Review

Stonegate Investment Group reduced its Cardinal Health (CAH) stake by 33% in Q3 2025, selling an estimated $203K and leaving 2,680 shares worth $421K. The position accounts for 0.01% of the portfolio, ranked #270.

Stonegate Investment Group first reported a position in CAH in Q2 2024 and has held it in 6 quarters since. The position peaked at $671K in Q2 2025. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Stonegate Investment Group held 2,680 shares of Cardinal Health worth $421K as of Q3 2025.
  • Stonegate Investment Group sold 1,315 Cardinal Health shares in Q3 2025, an estimated $203K.
  • Cardinal Health made up 0.01% of Stonegate Investment Group's portfolio in Q3 2025, its #270 holding.
  • Stonegate Investment Group first reported a position in Cardinal Health in Q2 2024 and has held it in 6 quarters since.
  • Stonegate Investment Group's Cardinal Health position peaked at $671K in Q2 2025.
  • 1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.